Candriam Equities L Biotech.C EUR
ISIN: LU1120766388 | WKN: A2DLUB
KAG: Candriam
NAV: 232,83 EUR am 26.09.2024
Monatsperformance Candriam Equities L Biotech.C EUR
| 2024 | 2023 | 2022 | 2021 | 2019 |
Januar | +3,19% | +1,12% | -9,30% | - | +12,70% |
Februar | +1,72% | -3,40% | -1,76% | - | +4,36% |
März | +0,15% | -2,17% | +7,03% | - | +0,82% |
April | -5,32% | +0,63% | -2,16% | - | -4,77% |
Mai | +2,24% | +2,56% | -5,45% | - | -3,93% |
Juni | +7,00% | -0,90% | +6,05% | - | +7,06% |
Juli | +5,30% | -1,63% | +7,35% | +31,91% | +0,91% |
August | -0,55% | +1,34% | +2,94% | +4,35% | - |
September | -3,74% | -2,10% | +0,68% | -2,47% | - |
Oktober | - | -5,97% | +5,55% | +0,30% | - |
November | - | +2,83% | +1,91% | -1,70% | - |
Dezember | - | +12,21% | -6,30% | +1,34% | - |
Gesamt | +9,76% | +3,49% | +4,91% | +34,14% | +17,20% |
Performanceverteilung in Monats-Bausteinen
| | | | | 5/24 | | | | | |
| | | | 9/24 | 3/24 | | | | | |
| | | | 8/24 | 2/24 | | | | | |
| | | | 9/23 | 1/24 | | | | | |
| | | | 7/23 | 11/23 | | | | | |
| | | | 6/23 | 8/23 | | | | | |
| | | | 3/23 | 5/23 | | | | | |
| | | | 2/23 | 4/23 | | | | | |
| | | | 4/22 | 1/23 | | | | | |
| | | | 2/22 | 11/22 | | | | | |
| | | | 11/21 | 9/22 | | | | | |
| | | | 9/21 | 8/22 | | | | | |
| | | | 5/19 | 12/21 | | | | | |
| | | | 4/19 | 10/21 | 7/24 | | | | |
| | | | 9/18 | 8/21 | 6/24 | | | | |
| | | | 4/18 | 7/19 | 10/22 | | | | |
| | | | 3/18 | 3/19 | 7/22 | | | | |
| | | | 2/18 | 2/19 | 6/22 | | | | |
| | | | 11/17 | 11/18 | 3/22 | | | | |
| | | 4/24 | 7/17 | 8/18 | 6/19 | | | | |
| | | 10/23 | 4/17 | 7/18 | 5/18 | | | | |
| | | 12/22 | 3/17 | 6/18 | 8/17 | | | | |
| | | 5/22 | 12/16 | 1/18 | 6/17 | | | | |
| | | 1/22 | 8/16 | 12/17 | 2/17 | | | | |
| | 10/18 | 12/18 | 3/16 | 9/17 | 5/16 | 12/23 | | | |
| | 10/16 | 10/17 | 2/16 | 1/17 | 11/15 | 1/19 | | | |
| | 9/15 | 5/17 | 12/15 | 9/16 | 10/15 | 11/16 | | | |
1/16 | | 8/15 | 6/16 | 6/15 | 4/16 | 7/15 | 7/16 | | 7/21 | |
-20% | -15% | -10% | -5% | 0% | 0% | 5% | 10% | 15% | 20% |